Revance Therapeutics (NASDAQ:RVNC) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Revance Therapeutics missed estimated earnings by 3.3%, reporting an EPS of $-0.94 versus an estimate of $-0.91.
Revenue was up $11.96 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 12.01% increase in the share price the next day.
Here's a look at Revance Therapeutics's past performance:
|Quarter||Q4 2021||Q3 2021||Q2 2021||Q1 2021|
To track all earnings releases for Revance Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.